|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls001495847 |
| 003 |
SK-MaSNL |
| 005 |
20260303073338.0 |
| 008 |
050218c2002 xo 0 slo |
| 015 |
|
|
|a SNBCL2005/2
|
| 040 |
|
|
|a SLKCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
|
|
|a slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.12-008.64-085
|2 1981
|
| 100 |
1 |
|
|a Blake, G.J.
|4 apd
|9 1074804
|
| 245 |
1 |
0 |
|a Predpokladaný zisk v očakávanej dĺžke života pri terapii statínmi u jedincov so zvýšenými koncentráciami C-reaktívneho proteínu
|c G.J. Blake, P.M. Ridker, K.M. Kuntz
|
| 500 |
|
|
|a J Am Coll Cardiol 2002:40:49-55 Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a dĺžka života, predpokladaná
|2 MESH
|9 1074805
|
| 650 |
0 |
7 |
|a inhibítory hydroxymetylglutaryl-CoA-reduktázy
|x aplikácia a dávkovanie
|2 MESH
|9 1074806
|
| 650 |
0 |
7 |
|a C-reaktívny proteín
|x analýza
|2 MESH
|9 1074807
|
| 650 |
0 |
7 |
|a lipoproteíny, LDL
|x analýza
|2 MESH
|9 1074808
|
| 650 |
0 |
7 |
|a prognózy
|2 MESH
|9 3871
|
| 650 |
0 |
7 |
|a infarkt myokardu
|2 MESH
|9 2496
|
| 700 |
1 |
|
|a Ridker, P.M.
|4 apd
|9 1074809
|
| 700 |
1 |
|
|a Kuntz, K.M.
|4 apd
|9 1074810
|
| 773 |
0 |
|
|w SERIAL_GENERAL*000179*2002*002*004
|x 1335-8278
|t Journal of the American College of Cardiology
|g Roč. 2, č. 4 (2002), s. 277
|
| 850 |
|
|
|a Slovenská lekárska knižnica v Bratislave
|a BA006
|
| 852 |
|
|
|a BA006
|b KIS3GCP
|b 000500000
|
| 999 |
|
|
|c 1767348
|d 1769278
|
